Location History:
- Dolambreux, BE (1992)
- Delembreux, BE (2001)
- Dolembreux, BE (1995 - 2007)
Company Filing History:
Years Active: 1992-2007
Title: Jacques Delarge: Innovator in Pyridinic Sulfonamide Derivatives
Introduction
Jacques Delarge is a notable inventor based in Dolembreux, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyridinic sulfonamide derivatives. With a total of 7 patents to his name, Delarge has established himself as a key figure in the development of therapeutic substances.
Latest Patents
One of Delarge's latest patents focuses on pyridinic sulfonamide derivatives, detailing a method of production and their applications. These derivatives are represented by a general formula (I), wherein R1 denotes a mono- or polyhalogenated C1–12-alkyl or a mono- or poly-halogenated C3–8-cycloalkyl group. The patent outlines the method of production for these derivatives and their potential use as active therapeutic substances in treating various diseases, including inflammation, arthrosis, cancer, angiogenesis, and asthma. Another significant patent involves coumarin derivatives, which also includes methods of preparation and their application as medicines.
Career Highlights
Throughout his career, Jacques Delarge has worked with reputable organizations, including Adir Et Compagnie and the Centre National De La Recherche Scientifique. His work has contributed to advancements in medicinal chemistry and has had a positive impact on the development of new therapeutic agents.
Collaborations
Delarge has collaborated with esteemed colleagues such as Bernard Pirotte and Bernard Masereel. These partnerships have further enriched his research and innovation in the field.
Conclusion
Jacques Delarge's contributions to the field of medicinal chemistry, particularly through his patents on pyridinic sulfonamide derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic treatments.